ArticleOncoimmunology2024

Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.

Yikun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.